Internal Medicine, Nephrology · Colton, CA
NPI
1689907461
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
400 N Pepper Ave
Colton, CA, 92324
Phone (909) 835-7946
Groups this clinician bills Medicare through
Medicare paid, 2024
$244K
2,037 services
Medicare patients, 2024
366
Average age 65
Drug cost, 2024
$1.4M
2,498 prescriptions
Company payments, 2025
$323
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pooja M Badlani was code 90960 (esrd related services (not dialysis)), 311 times for 41 patients. In total Pooja M Badlani billed 2,037 services in 19 codes, and Medicare paid $244K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Facility | 311 | 41 | $263.51 | $82K |
| 99232 Hospital E&M - Subsequent | Facility | 302 | 89 | $58.37 | $18K |
| 99214 Office E&M - Established | Facility | 272 | 123 | $52.44 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 241 | 112 | $12.23 | $2,947 |
| 90935 Hemodialysis | Facility | 238 | 72 | $52.54 | $13K |
| 90966 ESRD Related Services (not dialysis) | Office | 144 | 22 | $212.95 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 97 | 47 | $87.73 | $8,510 |
| 90960 ESRD Related Services (not dialysis) | Office | 76 | 46 | $232.82 | $18K |
| 90961 ESRD Related Services (not dialysis) | Office | 76 | 56 | $208.29 | $16K |
| 90961 ESRD Related Services (not dialysis) | Facility | 51 | 27 | $219.44 | $11K |
| 99223 Hospital E&M - Initial | Facility | 47 | 43 | $124.13 | $5,834 |
| 99222 Hospital E&M - Initial | Facility | 39 | 33 | $95.96 | $3,742 |
| 99204 Office E&M - New | Facility | 34 | 34 | $89.99 | $3,060 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 24 | 17 | $213.84 | $5,132 |
| 99215 Office E&M - Established | Facility | 21 | 19 | $87.22 | $1,832 |
By year: 2022 $140K for 1,021 services; 2023 $193K for 1,139 services; 2024 $244K for 2,037 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pooja M Badlani prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 239 prescriptions and refills. In total Pooja M Badlani wrote 2,498 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 239 | 320 | 63 | $158K |
| Losartan Potassium Generic | 229 | 421 | 82 | $1,645 |
| Dapagliflozin Dapagliflozin Propanediol | 174 | 232 | 42 | $102K |
| Carvedilol Generic | 158 | 272 | 57 | $1,054 |
| Sevelamer Carbonate Generic | 153 | 300 | 65 | $44K |
| Lisinopril Generic | 106 | 166 | 32 | $466 |
| Furosemide Generic | 95 | 189 | 39 | $581 |
| Ozempic Semaglutide | 78 | 86 | 18 | $68K |
| Hydralazine Hcl Generic | 71 | 131 | 27 | $883 |
| Amlodipine Besylate Generic | 66 | 137 | 32 | $242 |
| Cinacalcet Hcl Generic | 65 | 110 | 14 | $24K |
| Nifedipine Er Nifedipine | 61 | 110 | 26 | $1,933 |
| Velphoro Sucroferric Oxyhydroxide | 52 | 74 | 18 | $191K |
| Lokelma Sodium Zirconium Cyclosilicate | 49 | 73 | 20 | $51K |
| Sevelamer Hcl Generic | 41 | 77 | 16 | $50K |
Brand drugs: - claims; generic drugs: 1,685 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pooja M Badlani $323 ($323 in general payments such as food, travel and fees) from 5 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $160.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.